The Ocular Surface of Glaucoma Patients Treated over the Long Term Expresses Inflammatory Markers Related to Both T-Helper 1 and T-Helper 2 Pathways

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

Raffaella Bonecchi, Paola Panina‐Bordignon, Daniele D’Ambrosio et al. · The Journal of Experimental Medicine · 1998 · 2K citations · Full text

Life Sciences, Immunology, Cell Signaling +16

Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication

Pierre‐Jean Pisella · British Journal of Ophthalmology · 2002 · 613 citations · Full text

Medicine, Ophthalmology, Toxicology +16

Experimental Dry Eye Stimulates Production of Inflammatory Cytokines and MMP-9 and Activates MAPK Signaling Pathways on the Ocular Surface

Lihui Luo, De‐Quan Li, Amish Doshi et al. · Investigative Ophthalmology & Visual Science · 2004 · 592 citations

Medicine, Immunology, Ophthalmology +17

Adverse Effects of Topical Antiglaucoma Medication

David C. Broadway · Archives of Ophthalmology · 1994 · 525 citations

Medicine, Ophthalmology, Surgery +17

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure:

Richard Parrish, Paul Palmberg, Wang-Pui Sheu · American Journal of Ophthalmology · 2003 · 473 citations

Medicine, Ophthalmology, Surgery +9